Exosomes from patients with major depression cause depressive-like behaviors in mice with involvement of miR-139-5p-regulated neurogenesis

作者: Ze-Xu Wei , Guo-Jun Xie , Xiao Mao , Xin-Peng Zou , Ya-Jin Liao

DOI: 10.1038/S41386-020-0622-2

关键词:

摘要: Exosomal microRNAs (miRNAs) have been suggested to participate in the pathogenesis of neuropsychiatric diseases, but their role major depressive disorder (MDD) is unknown. We performed a genome-wide miRNA expression profiling blood-derived exosomes from MDD patients and control subjects revealed top differentially expressed exosomal miRNA, i.e. hsa-miR-139-5p (upregulation), had good performance differentiate between controls. Tail vein injection blood isolated into normal mice caused depressive-like behaviors as determined by forced swimming, tail suspension, novelty suppressed feeding tests, healthy volunteers unpredictable mild stress (CUMS)-treated alleviated behaviors. CUMS also showed significantly increased brain levels miR-139-5p. Furthermore, CUMS-treated were rescued intranasal miR-139-5p antagomir, suggesting that may mediate stress-induced depression-like behavior mice. Both exosome treatment antagomir hippocampal neurogenesis mice, decreased The was validated vitro experiments, demonstrating negative regulator for neural stem cell proliferation neuronal differentiation. Our findings together suggest with depression involvement miR-139-5p-regulated neurogenesis. Therefore, miRNAs are promising targets diagnosis MDD.

参考文章(40)
Anjali L. Varigonda, Ewgeni Jakubovski, Matthew J. Taylor, Nick Freemantle, Catherine Coughlin, Michael H. Bloch, Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. ,vol. 54, pp. 557- 564 ,(2015) , 10.1016/J.JAAC.2015.05.004
Sara Jiménez-Fernández, Manuel Gurpegui, Francisco Díaz-Atienza, Lucía Pérez-Costillas, Miriam Gerstenberg, Christoph U. Correll, Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis. The Journal of Clinical Psychiatry. ,vol. 76, pp. 1658- 1667 ,(2015) , 10.4088/JCP.14R09179
Michel Hamon, Pierre Blier, Monoamine neurocircuitry in depression and strategies for new treatments. Progress in Neuro-psychopharmacology & Biological Psychiatry. ,vol. 45, pp. 54- 63 ,(2013) , 10.1016/J.PNPBP.2013.04.009
W.N. Marsden, Synaptic plasticity in depression: molecular, cellular and functional correlates. Progress in Neuro-psychopharmacology & Biological Psychiatry. ,vol. 43, pp. 168- 184 ,(2013) , 10.1016/J.PNPBP.2012.12.012
Y Cheng, R M Rodriguiz, S R K Murthy, V Senatorov, E Thouennon, N X Cawley, D K Aryal, S Ahn, B Lecka-Czernik, W C Wetsel, Y P Loh, Neurotrophic Factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone Molecular Psychiatry. ,vol. 20, pp. 744- 754 ,(2015) , 10.1038/MP.2014.136
Jason S. Snyder, Amélie Soumier, Michelle Brewer, James Pickel, Heather A. Cameron, Adult hippocampal neurogenesis buffers stress responses and depressive behaviour Nature. ,vol. 476, pp. 458- 461 ,(2011) , 10.1038/NATURE10287
Alexis S Hill, Amar Sahay, René Hen, Increasing Adult Hippocampal Neurogenesis is Sufficient to Reduce Anxiety and Depression-Like Behaviors. Neuropsychopharmacology. ,vol. 40, pp. 2368- 2378 ,(2015) , 10.1038/NPP.2015.85
Jian Zhang, Sha Li, Lu Li, Meng Li, Chongye Guo, Jun Yao, Shuangli Mi, Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics, Proteomics & Bioinformatics. ,vol. 13, pp. 17- 24 ,(2015) , 10.1016/J.GPB.2015.02.001
Jacek R Wiśniewski, Alexandre Zougman, Nagarjuna Nagaraj, Matthias Mann, Universal sample preparation method for proteome analysis Nature Methods. ,vol. 6, pp. 359- 362 ,(2009) , 10.1038/NMETH.1322
Joshua G. Hunsberger, Daniel R. Austin, Guang Chen, Husseini K. Manji, MicroRNAs in Mental Health: From Biological Underpinnings to Potential Therapies Neuromolecular Medicine. ,vol. 11, pp. 173- 182 ,(2009) , 10.1007/S12017-009-8070-5